blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2044077

EP2044077 - DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.08.2017
Database last updated on 22.05.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Glaxo Group Limited
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2013/18]
Former [2009/15]For all designated states
Glaxo Group Limited
Glaxo Wellcome House Berkeley Avenue Greenford Middlesex
UB6 0NN / GB
Inventor(s)01 / BALLELL, Lluis
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
02 / BARROS, David
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
03 / BROOKS, Gerald
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
04 / CASTRO PICHEL, Julia
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
05 / DABBS, Steven
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
06 / DAINES, Robert, A
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
07 / DAVIES, David, Thomas
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
08 / FIANDOR ROMAN, Jose Maria
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
09 / GIORDANO, Ilaria
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
10 / HENNESSY, Alan, Joseph
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
11 / HOFFMAN, James, B
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
12 / JONES, Graham, Elgin
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
13 / MILES, Timothy, James
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
14 / PEARSON, Neil, David
c/o GlaxoSmithKline
1250 S. Collegeville Rd
Collegeville, Pennsylvania 19426 / US
15 / PENDRAK, Israil
c/o GlaxoSmithKline
709 Swedeland Road No.1539
King of Prussia, PA 19406 / US
16 / REMUINAN BLANCO, Modesto, J
c/o GlaxoSmithKline
P.T.M. Severo Ochoa, 2
28760 Tres Cantos, Madrid / ES
17 / ROSSI, Jason, Anthony
c/o GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
18 / ZHANG, Lihua(Lily)
c/o GlaxoSmithKline
1250 S. Collegeville Rd
Collegeville, Pennsylvania 19426 / US
 [2016/40]
Former [2009/15]01 / BALLELL, Lluis
GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa
28760 Tres Cantos, Madrid / ES
02 / BARROS, David
GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa
28760 Tres Cantos, Madrid / ES
03 / BROOKS, Gerald
c/o GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
04 / CASTRO PICHEL, Julia
GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa
28760 Tres Cantos, Madrid / ES
05 / DABBS, Steven
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
06 / DAINES, Robert, A
GlaxoSmithKline 1250 South Collegeville Road PO Box 5089
Collegeville, Pennsylvania 19426-0989 / US
07 / DAVIES, David, Thomas
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
08 / FIANDOR ROMAN, Jose Maria
GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa
28760 Tres Cantos, Madrid / ES
09 / GIORDANO, Ilaria
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
10 / HENNESSY, Alan, Joseph
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
11 / HOFFMAN, James, B
GlaxoSmithKline 1250 South Collegeville Road PO Box 5089
Collegeville, Pennsylvania 19426-0989 / US
12 / JONES, Graham, Elgin
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
13 / MILES, Timothy, James
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
14 / PEARSON, Neil, David
GlaxoSmithKline New Frontiers Science Park South Third Avenue
Harlow Essex CM19 5AW / GB
15 / PENDRAK, Israil
GlaxoSmithKline 1250 South Collegeville Road PO Box 5089
Collegeville, Pennsylvania 19426-0989 / US
16 / REMUINAN BLANCO, Modesto, J
GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa
28760 Tres Cantos, Madrid / ES
17 / ROSSI, Jason, Anthony
GlaxoSmithKline 1250 South Collegeville Road PO Box 5089
Collegeville, Pennsylvania 19426-0989 / US
18 / ZHANG, Lihua(Lily)
GlaxoSmithKline 1250 South Collegeville Road PO Box 5089
Collegeville, Pennsylvania 19426-0989 / US
Representative(s)Quillin, Helen Kaye, et al
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2016/40]
Former [2009/15]Valentine, Jill Barbara, et al
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date07802383.518.07.2007
[2009/15]
WO2007EP57422
Priority number, dateUS20060807850P20.07.2006         Original published format: US 807850 P
US20070913057P20.04.2007         Original published format: US 913057 P
EP2007038104118.05.2007         Original published format: EP 07381041
[2009/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008009700
Date:24.01.2008
Language:EN
[2008/04]
Type: A1 Application with search report 
No.:EP2044077
Date:08.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 24.01.2008 takes the place of the publication of the European patent application.
[2009/15]
Type: B1 Patent specification 
No.:EP2044077
Date:05.10.2016
Language:EN
[2016/40]
Search report(s)International search report - published on:EP24.01.2008
ClassificationIPC:C07D401/14, C07D405/14, C07D409/14, C07D417/14, C07D471/04, C07D491/04, C07D497/04, C07D498/04, C07D513/04, C07D519/00, // A61K31/538, A61K31/519, A61P31/04
[2015/34]
CPC:
C07D491/04 (EP,KR,US); A61K31/519 (EP,US); A61K31/538 (EP,US);
A61P31/04 (EP); A61P31/06 (EP); C07D401/14 (EP,US);
C07D405/14 (EP,US); C07D409/14 (EP,US); C07D417/14 (EP,US);
C07D471/04 (EP,US); C07D497/04 (EP,KR,US); C07D498/04 (EP,KR,US);
C07D513/04 (EP,KR,US); C07D519/00 (EP,US) (-)
Former IPC [2009/15]C07D491/04, C07D497/04, C07D498/04, C07D513/04, C07D519/00, A61P31/04, A61P31/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/40]
Former [2009/15]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesHR16.01.2009
TitleGerman:DERIVATE UND ANALOGA VON N-ETHYLCHINOLONEN UND N-ETHYLAZACHINOLONEN[2009/15]
English:DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES[2009/15]
French:DÉRIVÉS ET ANALOGUES DE N-ÉTHYLQUINOLONES ET DE N-ÉTHYLAZAQUINOLONES[2009/15]
Entry into regional phase16.01.2009National basic fee paid 
16.01.2009Designation fee(s) paid 
16.01.2009Examination fee paid 
Examination procedure16.01.2009Amendment by applicant (claims and/or description)
16.01.2009Examination requested  [2009/15]
28.05.2009Despatch of a communication from the examining division (Time limit: M06)
04.12.2009Reply to a communication from the examining division
18.05.2012Despatch of a communication from the examining division (Time limit: M06)
22.11.2012Reply to a communication from the examining division
17.09.2015Communication of intention to grant the patent
12.01.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
11.02.2016Communication of intention to grant the patent
17.05.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.05.2016Fee for grant paid
17.05.2016Fee for publishing/printing paid
22.06.2016Communication of intention to grant the patent
25.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.05.2009
Opposition(s)06.07.2017No opposition filed within time limit [2017/37]
Fees paidRenewal fee
08.07.2009Renewal fee patent year 03
08.07.2010Renewal fee patent year 04
16.07.2011Renewal fee patent year 05
10.07.2012Renewal fee patent year 06
08.07.2013Renewal fee patent year 07
08.07.2014Renewal fee patent year 08
09.07.2015Renewal fee patent year 09
11.07.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.07.2007
AT05.10.2016
BE05.10.2016
CY05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
TR05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
[2020/15]
Former [2019/46]HU18.07.2007
AT05.10.2016
BE05.10.2016
CY05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2019/31]HU18.07.2007
AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2019/30]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
MC05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/52]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SI05.10.2016
SK05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/38]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SK05.10.2016
BG05.01.2017
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/36]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
SK05.10.2016
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/35]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
EE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
RO05.10.2016
SE05.10.2016
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/34]AT05.10.2016
BE05.10.2016
CZ05.10.2016
DK05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
SE05.10.2016
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/33]AT05.10.2016
BE05.10.2016
DK05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
SE05.10.2016
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/26]AT05.10.2016
BE05.10.2016
FI05.10.2016
LT05.10.2016
LV05.10.2016
NL05.10.2016
PL05.10.2016
SE05.10.2016
GR06.01.2017
IS05.02.2017
PT06.02.2017
Former [2017/12]LV05.10.2016
Cited inInternational search[PX]WO2006134378  (ASTRAZENECA AB [SE], et al) [PX] 1-8,11,16,21-23 * abstract * * page 7, line 5 - page 16, line 20; claim 12 * * example 1,4,8-10,12-16,18,20,55,66-99,101,102,107-115,120,121,124,125,127 *;
 [PX]WO2006137485  (TOYAMA CHEMICAL CO LTD [JP], et al) [PX] 1-5,7,8,16,21-23 * abstract * * paragraphs [0509] , [0511] , [0006] - [0537] - [0543] , [0544] , [0566] , [0568] , [0570] - [0579] - [0584] - [0620] * * paragraphs [0624] , [0637] - [0648] - [0669] , [0670] , [0673] - [0679] - [0683] - [0687] - [0690] - [0778] * * paragraphs [0781] , [0783] - [0846] - [0851] , [0852] , [0855] , [0857] , [0858] , [0861] , [0864] - [0869] * * paragraphs [0871] - [0886] - [0895] , [0899] , [0901] , [0905] , [0908] - [0917] *
 [A]  - ALI A Y ET AL, "Synthesis and antimicrobial activities of some quinoxalinonyl amino acid and peptide derivatives.", INDIAN JOURNAL OF CHEMISTRY, SECTION B: ORGANIC, INCL. MEDICINAL, PUBLICATIONS & INFORMATIONS DIRECTORATE, NEW DELHI, IN, (2003), vol. 42, no. 11, ISSN 0019-5103, pages 2835 - 2845, XP008085070 [A] 1-23 * the whole document *
 [A]  - DESHMUKH M B ET AL, "Synthesis of Biological activity of some New 1-Substituted-quinolone Derivatives", JOURNAL OF THE INDIAN CHEMICAL SOCIETY, THE INDIAN CHEMICAL SOCIETY, CALCUTTA, IN, (1997), vol. 74, no. 1, ISSN 0019-4522, pages 52 - 53, XP008085069 [A] 1-23 * the whole document *
ExaminationWO2007138974
by applicantWO0208224
 WO0250061
 WO02056882
 WO02096907
 WO03087098
 WO03010138
 WO03064421
 WO03064431
 WO2004002992
 WO2004002490
 WO2004014361
 WO2004041210
 WO2004096982
 WO0250036
 WO2004058144
 WO2004087145
 WO2006002047
 WO2006014580
 WO2006010040
 WO2006017326
 WO2006012396
 WO2006017468
 WO2006020561
 WO0125227
 WO0240474
 WO0207572
 WO2004035569
 WO2004089947
 WO2004024712
 WO2004024713
 WO2004087647
 WO2005016916
 WO2005097781
 WO2006010831
 WO2006021448
 WO2006032466
 WO2006038172
 WO2006046552
 WO2006134378
 WO2006137485
 EP1893599
 EP1900732
 EP2022793
 WO03082835
 WO0226723
 WO2006132739
 EP0559285
    - BAXTER, P.N.W.; KHOURY, R.G.; LEHN, J.M.; BAUM, G.; FENSKE, D., CHEMISTRY-A EUROPEAN JOURNAL, (2000), vol. 6, no. 22, page 4140
    - IRELAND ET AL., J. AMER. CHEM. SOC., (1973), page 7829
    - SYNLETT, (2003), vol. 15, pages 2428 - 2439
    - ANGEWANDTE CHEMIE, (2003), vol. 42, pages 5400 - 5449
    - T.A. WILLIAMSON, Heterocyclic Compounds, (1957), vol. 6, page 324
    - Comprehensive Heterocyclic Chemistry, vol. 3
    - Comprehensive Heterocyclic Chemistry, vol. 2
    - N.V. SAZONOV; T.S. SAFONOVA, KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, (1971), pages 1285 - 1288
    - PEACE; CARMAN; WULFMAN, SYNTHESIS, (1971), pages 658 - 661
    - KERINS, FERGAL; O'SHEA, DONAL F., J. ORG. CHEM., (2002), vol. 67, no. 14, page 4968
    - J. BIGS; P. SYKES, J. CHEMICAL SOCIETY, (1959), pages 1849 - 55
    - TANNER, A.C.; WU, C.C., "Adaptation of sensitive broth micro dilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum", AVIAN DISEASES, (1992), vol. 36, pages 74 - 717
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.